Skip to Content

W 275 (Lamotrigine Extended-Release 300 mg)

Pill with imprint W 275 is Pink, Round and has been identified as Lamotrigine Extended-Release 300 mg. It is supplied by Wockhardt USA LLC.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 275

Lamotrigine extended-release 300 mg W 275

Lamotrigine Extended-Release

Imprint
W 275
Strength
300 mg
Color
Pink
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wockhardt USA LLC
National Drug Code (NDC)
64679-0275
Inactive Ingredients
diethyl phthalate, ferric oxide red, hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.